羊水穿刺針の市場規模、シェア、動向分析レポート：タイプ別、処置別、最終用途別、地域別、セグメント別予測、2024年～2030年

羊水穿刺針市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の羊水穿刺針市場規模は2030年までに2億9,735万米ドルに達し、CAGR 6.85%で拡大すると予測されています。

この成長は、医療技術の進歩、出生前診断の需要増加を促す遺伝性疾患の有病率の上昇、低侵襲技術の継続的な開発など、いくつかの要因に起因する可能性があります。羊水穿刺針は潜在的なリスクを特定するために不可欠であるため、高い需要があります。しかし、羊水穿刺後の早期妊娠喪失に関して、産婦人科の分野では差し迫った懸念があります。

世界の遺伝性疾患の増加は、出生前診断における羊水穿刺針のような精密なツールの需要を大幅に押し上げています。このような遺伝的疾患の有病率の増加は、胎児の潜在的な問題を正確かつ早期に検出する方法の差し迫った必要性を浮き彫りにしています。羊水穿刺針のような先進的なツールの重要性は、遺伝性疾患の深刻な健康への影響により、より良い出生前ケアへの需要が高まっていることによって強調されています。例えば、MJHライフサイエンス社の2022年の報告書では、遺伝性疾患による世界の負担の増大に焦点が当てられており、年間約30万人の赤ちゃんが鎌状赤血球症で生まれ、世界人口の5％近くが影響を受けていることが明らかにされています。

女性が出産を高齢出産に先延ばしする傾向が広まっています。母親の年齢が高くなると、胎児の染色体異常のリスクが高まるため、羊水穿刺は重要な診断ツールとなります。羊水穿刺後の早期流産の発生は、産科と婦人科の分野では重要な懸念事項です。この現象の要因を明らかにすることが極めて重要です。研究によって様々な発生率が報告されており、10％前後という高い発生率を示唆するものもあります。その結果、この年齢に関連した要因が羊水穿刺針の需要を大きく促進しています。

さらに、妊婦の間で糖尿病や高血圧などの慢性疾患の有病率が増加していることから、より包括的な出生前スクリーニングの需要が高まっています。The Global Library of Women's Medicineが発表した2021年の調査論文によると、WHOの基準では、世界の妊娠の約16.9％が妊娠中の高血糖の影響を受けていると推定されています。このような病態の発生率は増加傾向にあり、肥満率の増加、母体の高齢化、スクリーニングや診断基準の変化などがその要因となっています。さらに、医療専門家は、遺伝性疾患の早期発見の重要性をますます認識するようになっています。したがって、羊水穿刺はこれらの健康課題に対処する女性に頻繁に推奨され、胎児の健康を評価する重要な手段を提供しています。

羊水穿刺針市場レポートハイライト

• 2023年には、100-150mmセグメントが最大の市場シェアを占めました。これは、出生前処置における多様な臨床要件に対応する最適な長さによるものと考えられます。
• 正確で信頼性の高い出生前診断への需要の高まりと遺伝子異常の有病率の増加により、2023年には羊水穿刺処置セグメントが処置セグメントを支配しました。
• 病院は、羊水穿刺を含む包括的な出生前サービスを提供しており、これらの針の主要なユーザーとなっているため、2023年の最終用途セグメントは病院セグメントが支配的でした。
• 北米地域は、高度な医療インフラ、出生前検査に関する認知度の向上、高度医療技術の採用率の上昇、遺伝子異常の有病率の上昇により、2023年に市場の最大シェアを占めました。
• 市場プレーヤーは、製品リーチを拡大し、多様な地域での利用可能性を向上させるために、いくつかの戦略的イニシアチブを採用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 羊水穿刺針市場：変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 羊水穿刺針市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 羊水穿刺針市場：タイプの推定・動向分析

• 定義と範囲
• タイプの市場シェア、2018年および2030年
• セグメントダッシュボード
• タイプ別の世界の羊水穿刺針市場の見通し
• 市場規模、予測および動向分析、2018年～2030年

第5章 羊水穿刺針市場：処置の推定・動向分析

• 定義と範囲
• 処置の市場シェア、2018年および2030年
• セグメントダッシュボード
• 処置別の世界の羊水穿刺針市場の見通し
• 市場規模、予測および動向分析、2024年～2030年

第6章 羊水穿刺針市場：最終用途の推定・動向分析

• 定義と範囲
• 最終用途の市場シェア、2018年および2030年
• セグメントダッシュボード
• 最終用途別の世界の羊水穿刺針市場の見通し
• 市場規模、予測および動向分析、2024年～2030年

第7章 羊水穿刺針市場：地域の推定・動向分析

• 地域の市場シェア分析、2023年および2030年
• 地域の市場ダッシュボード
• 世界の地域の市場スナップショット
• 市場規模と予測動向分析、2018年～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業別の最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • Smith's Medical
  • Biopsybell Srl
  • Integra LifeSciences
  • Laboratoire CCD
  • Cook Medical
  • RI.MOS. Srl
  • CooperSurgical
  • Medline
  • Rocket Medical
  • Becton Dickinson and Company

List of Tables

• Table 1 List of regulatory bodies for different countries
• Table 2 Key companies' product launches
• Table 3 Key companies' merger and acquisitions
• Table 4 Key companies' collaboration
• Table 5 Other strategic initiatives of companies
• Table 6 North America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
• Table 7 North America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 8 North America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 9 North America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 10 U.S. amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 11 U.S. amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 12 U.S. amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 13 Canada amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 15 Canada amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Europe amniocentesis needle market, by country, 2018 - 2030 (USD Million)
• Table 17 Europe amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 18 Europe amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 19 Europe amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 20 UK amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 21 UK amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 22 UK amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 23 Germany amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 24 Germany amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 25 Germany amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 26 France amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 27 France amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 28 France amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Italy amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 30 Italy amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 31 Italy amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 32 Spain amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 33 Spain amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 34 Spain amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 35 Norway amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 36 Norway amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 37 Norway amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Sweden amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 39 Sweden amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 40 Sweden amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Denmark amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 42 Denmark amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 43 Denmark amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific amniocentesis needle market, by country, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Japan amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 49 Japan amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 50 Japan amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 51 China amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 52 China amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 53 China amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 54 India amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 55 India amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 56 India amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Australia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 58 Australia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 59 Australia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 60 South Korea amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 61 South Korea amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 62 South Korea amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Thailand amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 64 Thailand amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 65 Thailand amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Latin America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
• Table 67 Latin America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 68 Latin America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 69 Latin America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 70 Brazil amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 71 Brazil amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 72 Brazil amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 73 Mexico amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 74 Mexico amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 75 Mexico amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 76 Argentina amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 77 Argentina amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 78 Argentina amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa amniocentesis needle market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 83 South Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 84 South Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 85 South Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 89 UAE amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 90 UAE amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 91 UAE amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Kuwait amniocentesis needle market, by type, 2018 - 2030 (USD Million)
• Table 93 Kuwait amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
• Table 94 Kuwait amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Amniocentesis needle market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement process
• Fig. 4 Primary research pattern
• Fig. 5 Amniocentesis needle market snapshot, 2023 (USD Million)
• Fig. 6 Segment snapshot, USD Million
• Fig. 7 Competitive landscape snapshot
• Fig. 8 Penetration & growth prospect mapping, by product
• Fig. 9 Market driver analysis (Current & future impact)
• Fig. 10 Market restraint analysis (Current & future impact)
• Fig. 11 Amniocentesis needle market, type outlook key takeaways (USD Million)
• Fig. 12 Amniocentesis needle market: type movement analysis (USD Million), 2023 & 2030
• Fig. 13 100 to 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Smaller than 100 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Larger than 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Amniocentesis needle market: procedure movement analysis (USD Million), 2023 & 2030
• Fig. 17 Amniocentesis procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Amnioreduction procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Fetal blood transfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Amnioinfusion procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Cordocentesis procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Amniocentesis needle market, end use outlook key takeaways (USD Million)
• Fig. 23 Amniocentesis needle market: End use movement analysis (USD Million), 2023 & 2030
• Fig. 24 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Diagnostics centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Amniocentesis needle market: Regional key takeaways (USD Million)
• Fig. 29 Amniocentesis needle market: Regional outlook, 2023 & 2030, USD Million
• Fig. 30 North America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 U.S. amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Canada amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Europe amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 UK amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Germany amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 France amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Spain amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Italy amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Sweden amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Norway amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Denmark amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Asia Pacific amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 China amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Japan amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 India amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 South Korea amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Australia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Thailand amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Latin America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Brazil amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Mexico amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Argentina amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Middle East and Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 South Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 UAE amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 List of key emerging company's/technology disruptors/innovators

Amniocentesis Needle Market Growth & Trends:

The global amniocentesis needle market size is anticipated to reach USD 297.35 million by 2030, expanding at a CAGR of 6.85%, based on a new report by Grand View Research, Inc. This growth can be attributed to several factors like advancements in healthcare technology, a rising prevalence of genetic disorders prompting increased demand for prenatal diagnosis, and the continuous development of minimally invasive techniques. Amniocentesis needles are in high demand as they are essential for identifying potential risks. However, there is a pressing concern within the fields of obstetrics and gynecology regarding early pregnancy loss following amniocentesis.

The rise in genetic disorders worldwide is significantly boosting the demand for precise tools such as amniocentesis needles in prenatal diagnostics. This rising prevalence of genetic conditions highlights the pressing need for accurate and early detection methods for potential issues in unborn babies. The importance of advanced tools like amniocentesis needles is underscored by the growing demand for better prenatal care due to the serious health implications of genetic disorders. For instance, a 2022 report from MJH Life Sciences highlighted the escalating global burden of genetic diseases, revealing that around 300,000 babies are born with sickle cell disease annually, affecting nearly 5% of the world's population.

The trend of women delaying childbirth to older ages has gained prevalent traction. Advanced maternal age is inherently linked to a promoted risk of chromosomal abnormalities in the fetus, rendering amniocentesis comes in as a crucial diagnostic tool. The occurrence of early abortion following amniocentesis is a significant concern within the fields of obstetrics and gynecology. It's crucial to uncover the factors that contribute to this phenomenon. Studies have reported varying incidence rates, with some suggesting rates as high as around 10%. Consequently, this age-related factor significantly propels the demand for amniocentesis needles.

Furthermore, the increasing prevalence of chronic diseases such as diabetes and hypertension among expectant mothers has increased the demand for more comprehensive prenatal screening. According to a 2021 research paper published by The Global Library of Women's Medicine, it is estimated that approximately 16.9% of pregnancies worldwide are affected by hyperglycemia during pregnancy, as per WHO criteria. The incidence of such conditions is on the rise, attributed to factors like the increasing obesity rate, advanced maternal age, and changes in screening and diagnostic criteria. Moreover, healthcare professionals increasingly acknowledge the importance of early detection of genetic disorders. Thus, amniocentesis is frequently recommended for women dealing with these health challenges, providing a crucial means to assess fetal health.

Amniocentesis Needle Market Report Highlights:

• In 2023, the 100-150 mm segment accounted for the largest market share. This can be attributed due to its optimal length, which caters to diverse clinical requirements in prenatal procedures
• The amniocentesis procedures segment dominated the procedure segment in 2023 owing to the rising demand for accurate and reliable prenatal diagnosis and increasing prevalence of genetic abnormalities
• Hospitals segment dominated the end use segment in 2023 as they offer comprehensive prenatal services, including amniocentesis, making them key users of these needles
• The North American region held the largest share of the market in 2023 due to advanced healthcare infrastructure, increased awareness about prenatal testing, higher adoption rates of advanced medical technologies, and a rising prevalence of genetic disorders
• Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Procedure
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Procedure outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Amniocentesis Needle Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of gestational diabetes
    • 3.2.1.2. Increasing prevalence of genetic disorders and chromosomal abnormalities
    • 3.2.1.3. Rise in prenatal testing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Risk and invasiveness
    • 3.2.2.2. Alternative non-invasive testing
• 3.3. Amniocentesis Needle Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Amniocentesis Needle Market: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. 100 to 150 mm
  • 4.1.2. Larger Than 150 mm
  • 4.1.3. Smaller Than 100 mm
• 4.2. Type Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Amniocentesis Needle Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. 100 to 150 mm
    • 4.5.1.1. 100 to 150 mm market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Smaller Than 100 mm
    • 4.5.2.1. Smaller Than 100 mm market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Larger Than 150 mm
    • 4.5.3.1. Larger Than 150 mm market estimates and forecast 2018 to 2030s (USD Million)

Chapter 5. Amniocentesis Needle Market: Procedure Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Amniocentesis Procedures
  • 5.1.2. Amnioreduction Procedures
  • 5.1.3. Fetal Blood Transfusion
  • 5.1.4. Amnioinfusion Procedure
  • 5.1.5. Cordocentesis Procedure
• 5.2. Procedure Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Amniocentesis Needle Market by Procedure Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 5.5.1. Amniocentesis Procedures
    • 5.5.1.1. Amniocentesis procedures market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Amnioreduction Procedures
    • 5.5.2.1. Amnioreduction procedures market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Fetal Blood Transfusion
    • 5.5.3.1. Fetal blood transfusion market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Amnioinfusion Procedure
    • 5.5.4.1. Amnioinfusion procedure market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Cordocentesis Procedure
    • 5.5.5.1. Cordocentesis Procedure market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Amniocentesis Needle Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Diagnostics Centers
  • 6.1.3. Clinics
  • 6.1.4. Others
• 6.2. End-use Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Amniocentesis Needle Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Diagnostic Centers
    • 6.5.2.1. Diagnostic centers market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Clinics
    • 6.5.3.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Others
    • 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Amniocentesis Needle Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Smith's Medical
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Biopsybell Srl
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Integra LifeSciences
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Laboratoire CCD
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Cook Medical
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. RI.MOS. Srl
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. CooperSurgical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Medline
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Rocket Medical
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Becton Dickinson and Company
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives